EPIFUND | EMAS | |||||
---|---|---|---|---|---|---|
Cases N (%) | Controls N (%) | p Value* | Cases N (%) | Controls N (%) | p Value* | |
AA | 38 (27.1) | 37 (24.7) | 0.789 | 52 (25.6) | 243 (26.2) | 0.769 |
AG | 77 (55.0) | 82 (54.7) | 101 (49.8) | 479 (51.6) | ||
GG | 25 (17.9) | 31 (20.6) | 50 (24.6) | 207 (22.3) | ||
A | 153 (54.6) | 156 (52) | 0.524 | 205 (50.5) | 965 (51.9) | 0.598 |
G | 127 (45.3) | 144 (48) | 201 (49.5) | 893 (48.1) |
↵* p Value for genotype comparison is by Fisher's exact test and for allele comparison it is by χ2 test.
CWP, chronic widespread pain; EMAS, European Male Ageing Study; EPIFUND, Epidemiology of Functional Disorders.